SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

31 Oct 2023 07:00

RNS Number : 7845R
TP ICAP Group plc
31 October 2023
Β 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

Β 

31 October 2023

Β 

Β 

Trading update for the nine months ended 30 September 2023

Β 

Β 

Year-to-date performance (in constant currency, unless in brackets, which denotes reported currency)

Β 

Total Group revenue of Β£1,644m up 2% (+4% in reported currency). The Group in particular benefited from buoyant energy market conditions, with Energy & Commodities (E&C) leveraging its market-leading position across all the main asset classes.

At the divisional level, as expected, Global Broking (GB) revenue was down 1% (unchanged in reported currency), as the exceptional, volatility-driven volumes seen in 2022 did not re-occur in the first nine months of this year. In E&C, revenue was up 16% (+19%), with significant growth across the board.

Liquidnet division revenue was down 3% (-1%). There was a strong performance from the Relative Value business; Equities declined in line with subdued block market activity. Liquidnet's Dealer-to-Client Credit proposition progressing.

Β 

Parameta Solutions revenue was up 5% (+8%).

Β 

The Group continues to trade in line with the Board's expectations.

Β 

Third quarter performance: 1 July to 30 September 2023 (in constant currency, unless in brackets, which denotes reported currency)

Β 

Total Group revenue was Β£512m, up 5% (+1%).

Β 

GB revenue was down 2% (-6%), following a 12% increase in the revenue base for the same period last year. E&C revenue growth accelerated - up 28% (+22%) - reflecting the positive market developments, and the division's strong position.

Β 

Liquidnet's revenue increased by 6% (+3%). Growth in Equities more than offset a decline in the non-platform business.

Β 

Parameta Solutions revenue was up 7% (+2%).

Β 

Β 

2023 preliminary results

Β 

The Group will report its 2023 preliminary results on 12 March 2024.Β 

Β 

Β 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

Β 

Enquiries:

Group Company Secretary Vicky Hart Email: companysecretarial@tpicap.com

Β 

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com Β 

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

Β Β 

About TP ICAP

Β· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

Β· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

Β· We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

Β 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFFFEFIVLIVIV
Date   Source Headline
17th Jul 20149:00 amRNSDirectorate Change
10th Jul 201410:51 amRNSFINRA Arbitration
4th Jul 20144:08 pmRNSNotification of Half Year Results for 2014
23rd Jun 201410:34 amRNSHolding(s) in Company
3rd Jun 20145:49 pmRNSSuccession Planning - Chief Executive Officer
9th May 20144:36 pmRNSTullett Prebon PLC - Result of AGM
9th May 20147:00 amRNSAGM Statement and Interim Management Statement
9th May 20147:00 amRNSAcquisition of PVM
3rd Apr 20148:41 amRNSAnnual Financial Report
2nd Apr 20144:04 pmRNSHolding(s) in Company
25th Mar 20149:35 amRNSHolding(s) in Company
24th Mar 20149:18 amRNSHolding(s) in Company
4th Mar 20147:00 amRNSFinal Results
28th Jan 201410:19 amRNSDirectorate Change
22nd Jan 201412:14 pmRNSHolding(s) in Company
15th Jan 201410:42 amRNSNotice of Results
13th Nov 201312:57 pmRNSHolding(s) in Company
8th Nov 20137:00 amRNSInterim Management Statement
21st Oct 20133:46 pmRNSHolding(s) in Company
26th Sep 20138:00 amRNSCFTC grants SEF registration
27th Aug 20132:39 pmRNSHolding(s) in Company
23rd Aug 20133:45 pmRNSHolding(s) in Company
2nd Aug 20134:09 pmRNSHolding(s) in Company
30th Jul 20137:00 amRNSHalf Yearly Report
3rd Jul 201310:00 amRNSNotification of Half Year Results for 2013
20th Jun 20132:39 pmRNSStatement in relation to court proceedings
9th May 20132:52 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
3rd May 20138:40 amRNSDirector Declaration
24th Apr 201312:19 pmRNSHolding(s) in Company
18th Apr 20131:14 pmRNSAdditional Listing
18th Apr 20131:10 pmRNSDirector/PDMR Shareholding
4th Apr 20138:20 amRNSAnnual Financial Report
21st Mar 20131:20 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSFinal Results
1st Mar 20137:00 amRNSDirectorate Change
20th Feb 201310:25 amRNSNotice of Results
11th Feb 20135:05 pmRNSHolding(s) in Company
7th Feb 20133:47 pmRNSHolding(s) in Company
28th Jan 20135:08 pmRNSHolding(s) in Company
25th Jan 20134:23 pmRNSHolding(s) in Company
16th Jan 20134:06 pmRNSHolding(s) in Company
9th Jan 20134:13 pmRNSHolding(s) in Company
5th Dec 20122:50 pmRNSFinal Terms Confirmation Announcement
4th Dec 20121:00 pmRNSEarly Closure of Offer Period
22nd Nov 20129:00 amRNSPublication of Final Terms
15th Nov 20121:57 pmRNSPublication of Prospectus
13th Nov 201211:00 amRNSLitigation update
9th Nov 20127:00 amRNSInterim Management Statement
8th Nov 20122:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.